CEO Roopom Banerjee to Discuss Company’s Progress and Strategy at Stifel Nicolaus Healthcare Conference and UBS Global Life Sciences Conference
LEXINGTON, Mass., September 10, 2010 – RainDance Technologies, Inc., a private company pioneering microdroplet-based technologies for single-molecule and single-cell analysis, today announced that it will present at two upcoming investor conferences in September: the Stifel Nicolaus Healthcare Conference and the UBS Global Life Sciences Conference.
Roopom Banerjee, RainDance’s President and CEO, will provide an overview and discuss recent business performance and strategic initiatives at the Stifel Nicolaus Healthcare Conference in Boston on Wednesday, September 15 at 4:25 p.m. ET and the UBS Global Life Sciences Conference in New York City on Monday, September 20 at 2:00 p.m. ET.
“This has been a very exciting year for RainDance and the life sciences tools and diagnostics sector in general, and we are particularly encouraged by the recent level of investor interest in this market,” said Mr. Banerjee. “We look forward to meeting with the investment community at these conferences to discuss our track-record of success to-date and our strategic initiatives to expand applications of our novel microdroplet-based technology platform in life sciences research and medical genetics.”
For more information on RainDance Technologies, please visit www.raindancetech.com.
About RainDance Technologies
RainDance Technologies is pioneering the use of high-throughput microdroplet-based analysis in human health and life science research. The company’s core RainStorm™ technology generates millions of discrete droplets that can encapsulate a single molecule, cell or reaction and be digitally analyzed and sorted one at a time. The power, precision and simplicity of microdroplets enable researchers to answer complex questions with unprecedented sensitivity and quantitation. The complete RainDance solution includes automated instrumentation, customizable bioinformatics and high-value consumables and reagents for applications including targeted next-generation DNA sequencing, methylation, digital PCR and single cell analysis. Based in Lexington, Massachusetts, the company supports scientists around the world through its international sales and support operations and a global network of distributors and service providers. For more information, please visit www.RainDanceTech.com.
RainDance, RainStorm, ThunderStorm, Digital Biology are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.